Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Canature Health Technology Co., Ltd. (300272.SZ)
Shanghai, BJ, CN
Canature Health Technology Group Co., Ltd. engages in the research, development, manufacture, sale, and service of residential water treatment products. It operates through the following business segments: Water purification and softening equipment, Fireplace and furnace equipment, Maintenance, and Cell storage and other services. Its products include whole house water purifiers, whole house water softeners, commercial purification water dispensers, reverse osmosis membrane water purifiers, multi-control valves, and composite pressure vessels. The company was founded by Jian Guo Qu on February 27, 2001 and is headquartered in Shanghai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.07% | -10.38% | -18.16% | -22.70% | -16.60% | -18.05% | +0.16% | +16.32% | -23.38% | -27.71% | +50.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Machinery: +7.4%+9.0% ★ Q1'26: +3.0% (vs Q1'25)
-
EPS growth Industrial - Machinery: +15.6%-31.1% Q1'26: -79.8% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+4.5% Q1'26: +2.8% (vs Q1'25)
-
EBIT margin Industrial - Machinery: +10.0%+8.4% Q1'26: +7.0% (vs Q1'25)
-
ROIC Industrial - Machinery: +6.8%+7.8% ★ Q1'26: +4.8% (vs Q1'25)
-
Share dilution Industrial - Machinery: +0.0%+0.3% Q1'26: +6.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×4.85× Q1'26: 11.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|
| Revenue |
1.66B
est: 1.77B (-6.3%)
|
1.67B
est: 1.77B (-5.7%)
|
1.69B
est: 1.83B (-7.9%)
|
1.84B
est: 2.00B (-8.1%)
|
| EBITDA |
193.77M
est: 245.45M (-21.1%)
|
241.41M
est: 245.45M (-1.6%)
|
220.59M
est: 244.35M (-9.7%)
|
248.03M
est: 267.15M (-7.2%)
|
| EBIT |
141.02M
est: 166.93M (-15.5%)
|
191.39M
est: 166.93M (+14.7%)
|
173.24M
est: 182.51M (-5.1%)
|
155.06M
est: 199.53M (-22.3%)
|
| Net Income |
92.56M
est: 156.27M (-40.8%)
|
132.45M
est: 156.27M (-15.2%)
|
83.58M
est: 162.51M (-48.6%)
|
56.01M
est: 191.53M (-70.8%)
|
| SGA |
324.44M
est: 184.61M (+75.7%)
|
371.39M
est: 184.61M (+101.2%)
|
402.48M
est: 330.72M (+21.7%)
|
107.07M
est: 361.57M (-70.4%)
|
| EPS |
0.16
est: 0.27 (-40.7%)
|
0.24
est: 0.27 (-11.1%)
|
0.15
est: 0.28 (-46.4%)
|
0.10
est: 0.33 (-70.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Jin | Deputy GM & Non Independent Director | — | female |
| Raymond Ming Qu | GM & Vice Chairman | — | male |
| Wenjun Liu | Chief Financial Officer & Accounting Supervisor | — | male |
| Yanmao Xu | Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300272.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
